🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Primary Objectives: * VCDI cohort: * To determine the maximum tolerated...
Status
Completed
Location
Investigational Site Number : 250002
Start Date
2015-09-30
Trial ID
NCT02513186
Treatments Being Tested
The goal of this study is to evaluate sustained MRD negativity for one year...
Status
Recruiting
Location
The First Affiliated Hospital of Soochow University
Start Date
2024-06-12
Trial ID
NCT06409702
Treatments Being Tested
This is an open-label, single arm, multicenter, interventional study with D...
Status
Recruiting
Location
Hospital Clinico Universitario Salamanca
Start Date
2024-09-30
Trial ID
NCT06574126
The goal of this Phase 2, open-label, multicenter, non-randomized pilot stu...
Status
Active Not Recruiting
Location
Hospital Germans Trials i Pujol
Start Date
2023-09-21
Trial ID
NCT05849610
Treatments Being Tested
The goal of this clinical trial is to learn if anitocabtagene autoleucel fo...
Status
Recruiting
Location
Hospital Germans Trias i Pujol (ICO BADALONA)
Start Date
2025-06-30
Trial ID
NCT07045909
This randomized phase III trial compares bortezomib, dexamethasone, and len...
Status
Terminated
Location
Mayo Clinic in Arizona
Start Date
2007-09
Trial ID
NCT00522392
Treatments Being Tested
This is a Phase III open-label, 3-arm, parallel, randomized, controlled tri...
Status
Recruiting
Location
Hospital Principe de Asturias
Start Date
2022-11-10
Trial ID
NCT05558319
Treatments Being Tested
This is a Phase 2 study, open-label, 2-cohort, multicenter, national, inter...
Status
Active Not Recruiting
Location
CH de la Côte Basque
Start Date
2024-06-26
Trial ID
NCT06353022
Treatments Being Tested
Single-Arm phase 2 trial evaluating efficacy of incorporating Daratumumab t...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2021-10
Trial ID
NCT05054478
Treatments Being Tested
Toward improving the therapeutic index of standard TT3 (S-TT3), the investi...
Status
Active Not Recruiting
Location
University of Arkansas for Medical Sciences, Myeloma Institute for Research and Therapy
Start Date
2008-07
Trial ID
NCT00734877
Treatments Being Tested